EU medtech reform makes landmark move
This article was originally published in SRA
The overhaul of the EU medtech regulatory system has passed another important milestone after the Latvian Presidency of the Council of the European Union today reached an agreement on amendments to the European Commission’s proposed Medical Device Regulation and IVD Regulation1.
You may also be interested in...
In responding to industry’s plea for more time to comply with the EU’s MDR, the European Commission’s proposed one-year delay may also create some unwelcome repercussions for manufacturers and notified bodies.
With hospitals throughout the EU short of urgently needed COVID-19 medical supplies, including respiratory equipment, there are ways for companies to sell and deliver their products quickly.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.